QNRX
Quoin Pharmaceuticals Ltd DRC
NASDAQ: QNRX · HEALTHCARE · BIOTECHNOLOGY
$6.21
-4.17% today
Updated 2026-05-01
Market cap
$9.83M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-14.80
Dividend yield
—
52W range
$5 – $24
Volume
0.1M
Quoin Pharmaceuticals Ltd DRC (QNRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |